Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea Source: International Congress 2015 – Obstructive sleep apnoea in adults and children Year: 2015
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Intermittent hypoxia, the hallmark of sleep apnea, induces HIF-1-dependent mitochondrial dysfunction Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018
Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005
Obstructive sleep apnoea: the effect of intermittent hypoxia on cognitive function Source: ERS Conference Year: 2015
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
A simple device to subject cells to intermittent hypoxia mimicking obstructive sleep apnea Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012
Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice Source: Eur Respir J , 49 (2) 1602111; DOI: 10.1183/13993003.02111-2016 Year: 2017
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Source: Eur Respir J 2008; 32: 1082-1095 Year: 2008
Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients? Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4) 1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017
Changes in baroreflex activity in obstructive sleep apnea: cause or consequence? Source: Eur Respir J 2007; 30: Suppl. 51, 748s Year: 2007